Loro J F, Zhang J, Pfaffendorf M, van Zwieten P A
Departamento de Farmacología, Universidad de Las Palmas, Las Palmas de Gran Canaria, Spain.
Fundam Clin Pharmacol. 1998;12(1):77-81. doi: 10.1111/j.1472-8206.1998.tb00927.x.
The positive chronotropic effect of bradykinin was investigated in the pithed rat preparation. Cumulative treatment with bradykinin (0.20 nmol/kg-6.59 mumol/kg, intravenous [i.v.]) caused a dose-dependent increase in heart rate (HR) by a maximum of 80 +/- 3.3 beats min-1. In contrast, the active metabolite of bradykinin and selective bradykinin B1-receptor agonist, [des-Arg9]-bradykinin did not influence the spontaneous frequency of beating. Propranolol alone reduced the bradykinin-induced increase in HR and a combination of propranolol with prazosin abolished the chronotropic effect of bradykinin. The selective bradykinin B2 receptor antagonist. Hoe 140, dose-dependently shifted the dose-response curves of bradykinin to the right, whereas the bradykinin B1 receptor antagonist, des-Arg10-[Leu9]-kallidin proved ineffective. From our experiments it may be concluded that bradykinin induces tachycardia in the pithed rat primarily by stimulating the sympathetic ganglia leading to the release of noradrenaline, which subsequently activates cardiac beta 1-adrenoceptors. The bradykinin-induced chronotropic effect is mediated by bradykinin B2-receptors, whereas B1-receptors appear not to be involved.
在脊髓损毁大鼠制备模型中研究了缓激肽的正性变时作用。缓激肽(0.20 nmol/kg - 6.59 μmol/kg,静脉注射)累积给药导致心率(HR)呈剂量依赖性增加,最大增加幅度为80 ± 3.3次/分钟。相比之下,缓激肽的活性代谢产物及选择性缓激肽B1受体激动剂[去-精氨酸9]-缓激肽并不影响自发搏动频率。单独使用普萘洛尔可降低缓激肽诱导的HR增加,普萘洛尔与哌唑嗪联合使用则消除了缓激肽的变时作用。选择性缓激肽B2受体拮抗剂Hoe 140使缓激肽的剂量-反应曲线剂量依赖性地右移,而缓激肽B1受体拮抗剂去-精氨酸10-[亮氨酸9]-胰激肽则无效。从我们的实验可以得出结论,缓激肽在脊髓损毁大鼠中主要通过刺激交感神经节导致去甲肾上腺素释放,进而激活心脏β1 - 肾上腺素能受体来诱导心动过速。缓激肽诱导的变时作用由缓激肽B2受体介导,而B1受体似乎未参与其中。